Direct thrombin inhibitor use during percutaneous coronary intervention

Spyros Kokolis, Luther T. Clark, Erdal Cavusoglu, Jonathan D. Marmur

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Direct thrombin inhibitors (DTI) are emerging as alternative anticoagulants to unfractionated heparin and indirect thrombin inhibitors in patients undergoing percutaneous coronary intervention (PCI). We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI.

Original languageEnglish
Pages (from-to)270-279
Number of pages10
JournalJournal of Cardiovascular Pharmacology
Issue number3
StatePublished - Mar 2005
Externally publishedYes


  • Angioplasty
  • Bivalirudin
  • Percutaneous coronary intervention


Dive into the research topics of 'Direct thrombin inhibitor use during percutaneous coronary intervention'. Together they form a unique fingerprint.

Cite this